Search

everythinglearnresearchcommunity

for

Search:↓

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

Buserelin safely and effectively suppresses early puberty, potentially improving final height.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

A brain-produced steroid causes increased scratching in mice with a skin condition similar to eczema.

Retinoids may help treat lupus nephritis and reduce steroid use.

FOL-026 peptide can help repair blood vessels and promote growth, offering potential treatment for vascular diseases.

Alopecia can be reversed with timely steroid treatment in VKH and SO diseases.

Thevetia peruviana bark extract reduces pain in mice and may help create new painkillers.

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

Stress increases neurosteroids that help prevent seizures.

Certain drugs may cause vitiligo, so patients should be monitored.

Inhibiting 5α-reductase increases progesterone levels in late pregnant mares.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

GPR40 agonists help hair growth through the protein ANGPTL4.

Thoracic medial branch block may be a simpler and effective alternative to thoracic vertebroplasty for pain management.

Blocking neurosteroid production can lead to more seizures and faster epilepsy onset in rats.

Dracorhodin perchlorate helps heal wounds in diabetic rats by reducing inflammation.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Biofeedback treatment for dysfunctional voiding in adults showed no symptom improvement.

Vibration anesthesia effectively and safely reduces pain during botulinum toxin injections.

New compounds may soon be tested to treat excessive hair growth in women.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.